Screener
UroGen Pharma URGN Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Restricted cash | 1,329 | 1,350 |
| Accounts receivable, net | 88,757 | 33,082 |
| Inventories | 24,589 | 16,464 |
| Prepaid expenses and other current assets | 12,776 | 14,672 |
| Total current assets | 235,426 | 186,024 |
| Non-current assets: | ||
| Property and equipment, net | 597 | 637 |
| Restricted deposit | 178 | 177 |
Item 1. Financial Statements.
FAQ
- What is UroGen Pharma's prepaid & other current?
- UroGen Pharma (URGN) reported prepaid & other current of $12.78M in Q2 2026.
- How has UroGen Pharma's prepaid & other current changed year-over-year?
- UroGen Pharma's prepaid & other current increased by 6.0% year-over-year, from $12.06M to $12.78M.
- What is the long-term trend for UroGen Pharma's prepaid & other current?
- Over 5 years (2020 to 2025), UroGen Pharma's prepaid & other current has grown at a 34.3% compound annual growth rate (CAGR), from $3.36M to $14.67M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about UroGen Pharma's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude